Profile data is unavailable for this security.
About the company
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is focused on enhanced personalized cancer care through remote patient monitoring using implantable vascular access port with wireless communication combined with an oncologist-designed remote digital healthcare platform.
- Revenue in USD (TTM)3.83m
- Net income in USD-67.35m
- Incorporated2014
- Employees107.00
- LocationPAVmed Inc360 Madison Avenue, 25Th FloorNEW YORK 10017United StatesUSA
- Phone+1 (212) 949-4319
- Fax+1 (302) 655-5049
- Websitehttps://pavmed.com/